Nienke Elizabeth van Houten
Affiliations: | 2010- | Health Sciences | Simon Fraser University, Burnaby, British Columbia, Canada |
Area:
molecular immunology and vaccine designWebsite:
https://www.sfu.ca/fhs/people/profiles/nienke-van-houten.htmlGoogle:
"Nienke Elizabeth van Houten"Bio:
http://summit.sfu.ca/item/8330
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Jamie K. Scott | grad student | 2007 | Simon Fraser (Cell Biology Tree) | |
| (Strategies for the design of epitope targeting vaccines.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jariyapong P, Xing L, van Houten NE, et al. (2013) Chimeric hepatitis E virus-like particle as a carrier for oral-delivery. Vaccine. 31: 417-24 |
| Henry KA, Murira A, van Houten NE, et al. (2011) Developing strategies to enhance and focus humoral immune responses using filamentous phage as a model antigen Bioengineered Bugs. 2: 275-283 |
| van Houten NE, Henry KA, Smith GP, et al. (2010) Engineering filamentous phage carriers to improve focusing of antibody responses against peptides. Vaccine. 28: 2174-85 |
| Irving MB, Craig L, Menendez A, et al. (2010) Exploring peptide mimics for the production of antibodies against discontinuous protein epitopes. Molecular Immunology. 47: 1137-48 |
| Montero M, van Houten NE, Wang X, et al. (2008) The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiology and Molecular Biology Reviews : Mmbr. 72: 54-84, table of cont |
| Saphire EO, Montero M, Menendez A, et al. (2007) Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies. Journal of Molecular Biology. 369: 696-709 |
| van Houten NE, Zwick MB, Menendez A, et al. (2006) Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide. Vaccine. 24: 4188-200 |